Communiqué US
Launched in 2001, Communiqué US is now firmly established as an essential resource for the pharmaceutical industry. It is designed to help pharmaceutical executives understand and evaluate the benefits of effective PR and medical communications programs.
Communiqué US aims to promote greater understanding of the specialist skills of PR and medical communications practitioners, illustrating the need for pharmaceutical marketers to ensure that these disciplines receive adequate share of marketing spend.
Updated every six months with input from leading industry experts in the US, Communiqué US enjoys a circulation of over 4,000 across the country, including marketing, PR, medical communications, corporate communications, public affairs and procurement executives.
Communiqué US is the definitive guide to using and choosing healthcare PR and medical communications in the US.
Digital Edition:
The latest digital edition is free to registered users of PMLiVE.
Login or register with PMLiVE and you can be browsing this publication in minutes.
Useful information:
Subscribe to Communiqué US
For further information, rates and data and readership details, download the Communiqué US factsheet (pdf)
For editorial queries, contact Kate Fodor, editor of Communiqué US
For advertising opportunities, contact Gill Hollis, sales director
